Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
First Online: 30 June 2020
Compliance with ethical standards
:
: RBS reports speaking fees from Bristol-Myers Squibb/Pfizer. RBS further received funding from the European Union’s Horizon 2020 research and innovation programme under the (grant agreement No. 847770, AFFECT-EU), the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No. 648131), and ERACoSysMed3 (031L0239) and German Center for Cardiovascular Research (DZHK e.V.) (81Z1710103). KGH reports consulting fees/lecture honoraria from Bayer Healthcare, Biotronik, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Medronic, Pfizer, Sanofi, W.L. Gore and Associates, and study grants from Bayer HealthCare and Sanofi. SC reports no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
